Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Details for Australian Patent Application No. 2002239388 (hide)

Owner Aventis Pharmaceuticals, Inc.

Inventors Borcherding, David; Dumont, Jennifer A.; Wright, Paul S; Peet, Norton P.

Agent Watermark

Pub. Number AU-B-2002239388

PCT Pub. Number WO02/42303

Priority 0117075.2 13.07.01 GB; 60/244,567 31.10.00 US

Filing date 31 October 2001

Wipo publication date 3 June 2002

Acceptance publication date 25 May 2006

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

25 May 2006 Application Accepted

  Published as AU-B-2002239388

19 October 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239389-ENTERING AND EXITING POWER MANAGED STATES WITHOUT DISRUPTING ACCELERATED GRAPHICS PORT TRANSACTIONS

2002239387-INHIBITING GS-FDH TO MODULATE NO BIOACTIVITY